Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease (NAFLD).
Quantitative risk of mortality by fibrosis stage has not been systematically evaluated. …

Background & Aims Biopsy-confirmed liver fibrosis is a prognostic factor for patients with
nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to quantify the …

Chronic liver diseases are very common worldwide, particularly those linked to viral hepatitis
and to alcoholic and non-alcoholic fatty liver. Their natural history is variable and long-term …

BACKGROUND/AIMS: In chronic hepatitis C, biopsy is the gold standard for assessment of
liver fibrosis. Non-invasive markers have been proposed but their use is limited by diagnostic …

Chronic infection with hepatitis C virus (HCV) is a leading cause of liver-related morbidity
and mortality worldwide and predisposes to liver fibrosis and end-stage liver complications. …

BACKGROUND & AIMS: Non-invasive assessment of liver fibrosis is a challenging area.
Several methods have been proposed in patients with chronic hepatitis C (CHC) but their …

Liver fibrosis is characterized by the accumulation of extracellular matrix proteins such as
collagen in the liver interstitial space. All causes of chronic liver disease may lead to fibrosis …

Background The European AIDS Clinical Society (EACS) Guidelines cover key aspects of
HIV management with major updates every two years. Guideline highlights The 2019 …

The staging of liver fibrosis is pivotal for defining the prognosis and indications for therapy in
hepatitis C. Although liver biopsy remains the gold standard, several noninvasive methods …

The diagnostic assessment of liver injury is an important step in the management of patients
with chronic liver disease (CLD). Although liver biopsy is the reference standard for the …